Recombinant HPV vaccine

This page covers all Recombinant HPV vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Human papillomavirus L1 capsid protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58), Human papillomavirus types 6, 11, 16, 18, 31, 33, 45, 52, 58, HPV L1 capsid protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58).

Targets

Human papillomavirus L1 capsid protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58) · Human papillomavirus types 6, 11, 16, 18, 31, 33, 45, 52, 58 · HPV L1 capsid protein (types 6, 11, 16, 18, 31, 33, 45, 52, 58) · Human papillomavirus (HPV) virus-like particles · Human papillomavirus types 16 and 18 (L1 capsid protein) · Human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, 58

Marketed (3)

• Gardasil 9 Suspension for Injection · Erasmus Medical Center · Oncology / Immunology / Infectious Disease
  Gardasil 9 is a recombinant human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against nine HPV types to prevent infection and associated cancers.
• Gardasil 9 rescue dose · Boston Medical Center · Oncology / Immunology / Infectious Disease
  Gardasil 9 is a recombinant vaccine that stimulates the immune system to produce antibodies against nine types of human papillomavirus (HPV) to prevent infection and associated cancers.
• Gardasil9 · Boston Medical Center · Oncology / Immunology
  Gardasil9 is a recombinant vaccine that stimulates the immune system to produce antibodies against nine types of human papillomavirus (HPV) to prevent infection and associated cancers.

Phase 3 pipeline (3)

• GSK580299, GSK Biological's HPV vaccine · GlaxoSmithKline · Oncology / Immunology
  GSK580299 is an HPV vaccine that stimulates the immune system to produce antibodies and cellular immunity against human papillomavirus types associated with cervical cancer and other HPV-related malignancies.
• GSK580299 (CervarixTM) · GlaxoSmithKline · Oncology / Immunology
  Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates immune responses against HPV types 16 and 18 to prevent cervical cancer and related precancerous lesions.
• Active Comparator: GARDASIL ®9 · Shanghai Bovax Biotechnology Co., Ltd. · Oncology / Immunology / Infectious Disease
  GARDASIL 9 is a recombinant human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against nine HPV types to prevent infection and associated cancers.